University of Pennsylvania Health System to Equip New Cancer Treatment and Research Center with Technology from Varian Medical Systems
biz.yahoo.com
Thursday July 27, 8:05 am ET
Varian to provide full spectrum of products for delivering advanced, targeted radiotherapies
PALO ALTO, Calif., July 27 /PRNewswire-FirstCall/ -- The University of Pennsylvania Health System (UPHS), which is building a new world-class cancer treatment and research center, has selected, for its center, advanced cancer radiotherapy treatment technology from Varian Medical Systems (NYSE: VAR), including:
-- four Clinac iX(TM) accelerators equipped with On-Board Imager(TM)
devices for image-guided radiotherapy (IGRT), and high-resolution 120-
leaf multileaf collimators, which are beam shaping devices that make it
possible to deliver SmartBeam(TM) IMRT treatments,
-- an Acuity(TM) digital imaging device for treatment simulation and
verification,
-- 20 Eclipse® treatment planning workstations for planning all types of
external beam radiotherapy, including 3-D conformal, intensity-
modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and
proton treatments
-- the xArray(TM) optical guidance system for ultra-accurate patient
positioning,
-- accessories for delivering stereotactic radiosurgery (SRS),
-- RPM(TM) respiratory gating for synchronizing imaging and treatment with
a patient's respiratory cycle, in order to deal with tumor motion
during treatment, and
-- the ARIA(TM) oncology information system for managing administrative
and clinical information.
These products will be integrated within a new state-of-the-art cancer treatment facility being built as part of the Raymond and Ruth Perelman Center for Advanced Medicine (CAM), a $302 million center now under construction.
"UPHS is committed to providing cancer patients with the best care available anywhere in the world," said Michael J. Dandorph, senior vice president for business development at UPHS. "Our clinicians feel Varian's technology for delivering advanced forms of external-beam photon radiotherapy is unmatched for its power, precision, and versatility in treating the complex cancers we often encounter. The Varian products will enable our clinicians to design and deliver very personalized cancer treatments that zero in on malignancies and spare normal healthy tissues to the extent possible with IMRT technology."
"By assembling this complete set of interconnecting radiotherapy tools from Varian, UPHS is putting together a fully automated and integrated treatment and data network that will speed up processes and enable highly accurate treatments to take place quickly and efficiently," said Dow Wilson, president of Varian's Oncology Systems business. "We are delighted to support UPHS in building one of the most advanced, state-of-the-art cancer treatment centers anywhere in the world."
The new UPHS cancer treatment facility is expected to be ready for clinical use some time in 2008. |
